×

1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase

  • US 9,630,951 B2
  • Filed: 06/13/2013
  • Issued: 04/25/2017
  • Est. Priority Date: 05/08/2007
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating anxiety disorders;

  • migraine;

    cardiovascular disorders;

    hypertension, chronic or congestive heart failure;

    or one or more of the following indications;

    angina, arrhythmias, and circulatory disorders such as Raynaud'"'"'s phenomenon, comprising administering a therapeutically effective amount of a compound of formula X;

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×